Brunex Pharmaceuticals
Manufacturer
Company Description
Having established itself as a major Manufacturer and Exporter of R O S H Tablet around the world, Brunex Pharmaceuticals had been earning More than 6 Million US Dollar annually since its inception 18 Years ago. With an export rate of about Above US$100 Million earned yearly, the estimated market share of Brunex Pharmaceuticals is Australia,Canada,Germany,Nigeria,United Kingdom,United States. Having said all of this, European and Oceanic market is still yet to be discovered by the industry; however, this graph may change ahead in the future. Originating from NEW DELHI, , India, Brunex Pharmaceuticals started off with an initial investment of Above US$100 Million in 2002. A Corporation Limited Liability Company with Agency; the company plans to expand its roots in different countries in the coming years. For any further details on R O S H Tablet products, feel free to contact Mallikarjun on provided details.
| Company Name | Brunex Pharmaceuticals |
| Business Type | Manufacturer |
| Year Incorporated | 2002 |
| Major Selling Products | R O S H Tablet |
| Country | India |
| City | New Delhi, |
| Company Website | https://www.exporthub.com/brunex-pharmaceuticals |
| Contact Person | Mallikarjun |
| Department | Sales |
| Designation | Administrative |
| Chief Executive Officer | Mallikarjun |
| Total Workforce | 501 - 1000 People |
| Certificates | ISO14001 |
Buyer Interactions
Brunex Pharmaceuticals has responded 30% of buyers within 24 hours in past 30 days.
Brunex Pharmaceuticals average response time in past 7 days is greater than 72h.